Axis Capital Holdings (AXS)
(Delayed Data from NYSE)
$78.80 USD
-3.37 (-4.10%)
Updated Oct 7, 2024 04:00 PM ET
After-Market: $78.82 +0.02 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.80 USD
-3.37 (-4.10%)
Updated Oct 7, 2024 04:00 PM ET
After-Market: $78.82 +0.02 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth D Momentum B VGM
Zacks News
Axis Capital (AXS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Axis Capital (AXS) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Insurance Stocks' Q4 Earnings Due on Jan 31: AFL, MET & More
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to drive fourth-quarter results of insurers like AFL, MET, AXS, SIGI and MTG.
Gear Up for Axis Capital (AXS) Q4 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Axis Capital (AXS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Axis Capital (AXS) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Axis Capital (AXS) could produce exceptional returns because of its solid growth attributes.
Axis Capital (AXS) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Axis Capital (AXS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AXS or BRK.B: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AXS vs. BRK.B: Which Stock Is the Better Value Option?
Are Investors Undervaluing Axis Capital Holdings (AXS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Strength Seen in Axis Capital (AXS): Can Its 6.4% Jump Turn into More Strength?
by Zacks Equity Research
Axis Capital (AXS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Progressive's (PGR) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Progressive's (PGR) fourth-quarter 2023 results reflect year-over-year improvement in the top line.
AXIS Capital (AXS) Provides Preliminary 2023 Financial Results
by Zacks Equity Research
AXIS Capital (AXS) anticipates net income available to shareholders of $346 million, operating income of $486 million and book value per share of $54.06 for the year ended Dec 31, 2023.
Earnings Preview: Axis Capital (AXS) Q4 Earnings Expected to Decline
by Zacks Equity Research
Axis Capital (AXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 P&C Insurance Stocks With Decent Dividend Yield to Bank on
by Sushmita Sarker
Here we pick four insurance stocks, CNA Financial (CNA), American Financial (AFG), Travelers Companies (TRV) and Axis Capital (AXS), which have a solid five-year dividend growth history.
Nasdaq (NDAQ) Leverages AI to Enhance Anti-Fin Crime Offerings
by Zubia Masood
Nasdaq (NDAQ) makes heavy investments in technology to enhance its offerings related to anti-fin crime protection.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Synchrony (SYF) Expands CareCredit Offering With Destination Pet
by Zacks Equity Research
Synchrony (SYF) partners with Destination Pet to offer financing solutions to pet owners through its CareCredit card.
Is Axis Capital Holdings (AXS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why You Should Invest in Hartford Financial (HIG) Now
by Zacks Equity Research
Hartford Financial (HIG) remains poised for growth on the back of improving Commercial Lines and Group Benefits businesses. A strong financial position enables business investments.
Are Investors Undervaluing Arch Capital Group (ACGL) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MetLife (MET) Stock Gains 18.2% in 6 Months: More Room to Run?
by Zacks Equity Research
MetLife's (MET) improving performance in the United States and Asia business, coupled with cost-reduction initiatives, position the company well for growth.
Allstate (ALL) Up 29% in 6 Months: What's Ahead for Investors?
by Zacks Equity Research
Allstate (ALL) remains well-poised for growth on improved P&C insurance premiums, acquisitions and sufficient cash-generating abilities.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Why You Should Stay Invested in Axis Capital (AXS) Stock
by Zacks Equity Research
AXIS Capital (AXS) stands to gain from higher net investment income, strong market presence, better pricing, solid balance sheet and effective capital deployment.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
3 Value Stocks From the Undervalued P&C Insurance Space
by Sushmita Sarker
Leveraging improved pricing, technology advancements, global expansion and impressive solvency levels, undervalued insurers like AXS, RNR and CNA are poised to fetch better returns.